Latest papers

Development and validation of a HPLC-ESI-MS/MS method for the determination of 5-aminosalicylic acid and its major metabolite N-acetyl-5-aminosalicylic acid in human plasma.

De-novo [corrected] post renal transplantation inflammatory bowel disease.

Effects and treatment of inflammatory bowel disease during pregnancy.

Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.

[Ulcerative colitis. Main symptoms: bloody mucous diarrhea, tenesmus, abdominal pain]

Treatment of inflammatory bowel disease: a review of medical therapy.

Strategies to improve adherence and outcomes in patients with ulcerative colitis.

[Inflammatory bowel disease. Should aminosalicylates be administered in a single daily dose in ulcerative colitis?].

Radioprotection by copper and zinc complexes of 5-aminosalicylic acid: a preliminary study.

Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: a multicenter, prospective, internet-based study.

Novel 5-aminosalicylic acid formulations in ulcerative colitis: old dog, new tricks.

Synthesis and properties of N,N'-bis(5-aminosalicyl)-L-cystine as a colon-specific deliverer of 5-aminosalicylic acid and cystine.

5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.

Ulcerative colitis: diagnosis and treatment.

[Current medical treatment of inflammatory bowel disease]

Nonadherence in inflammatory bowel disease: results of factor analysis.

[Common errors in the management of outpatients with inflammatory bowel disease].

Ulcerative colitis: responding to the challenges.

Inhibition of human thiopurine S-methyltransferase by various nonsteroidal anti-inflammatory drugs in vitro: a mechanism for possible drug interactions.

Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.